Objective: To assess the effects of depression and anxiety on serum cytokine levels in patients with chronic hepatitis B (CHB) infection.
with CHB infection often experience chronic inflammation, which is associated with certain complications such as cirrhosis and hepatocellular carcinoma (HCC). The main reasons that chronic inflammation occurs have yet to be clarified in the literature. In addition to genetic and epigenetic factors, environmental factors can play critical roles in induction of inflammation. 2 Internal and environmental factors, are associated with several chronic infections, cancers, and chronic inflammatory-based diseases. 3 Accordingly, previous investigations demonstrated that depression and anxiety as the main causes of sadness and worry can alter immune responses in patients who suffer from chronic diseases. 4 Cytokines, as the main vehicles of the immune system, act as inflammatory and anti-inflammatory molecules that lead to acute or chronic inflammatory conditions. 5 Interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α are the main innate immunity cytokines that induce inflammation and immune Chronic hepatitis B (CHB) infection is a prolonged form of liver disease in which the immune system is unable to DOI:10.1093/labmed/lmx052
responses against viruses. 6, 7 Also, cytokines induce chronic inflammation in some situations, such as behavioral diseases and aging. 8, 9 In contrast, transforming growth factor-beta (TGF-β) is an anti-inflammatory cytokine and regulates the effects of inflammatory molecules. 10 TGF-β plays key roles in inhibition of chronic inflammation via development of T regulatory lymphocytes and, subsequently, suppression of immune responses. 11 TGF-β, in association with IL-6, participates in the development of Th17, the main cell type involved in induction of inflammation. 2 TGF-β also directly alters the functions of hepatocytes during HBV infection. 2 Therefore, each factor that leads to alteration in expression of IL-6, IL-8, TNF-α, and TGF-β may affect immune responses to HBV.
Thus, the main aim of this study was to evaluate expression levels of IL-6, IL-8, TNF-α, and TGF-β in patients with CHB infection compared with healthy control individuals and also in patients with CHB infection who have different degrees of depression and anxiety.
Materials and Methods

Subjects
In this cross-sectional study, peripheral blood specimens were obtained from 60 patients with CHB infection and 60 healthy controls and collected in freestanding anticoagulant tubes for separation of serum. All the patients with CHB infection had had it since childhood. The latter group was subdivided into 3 groups regarding depression and anxiety levels: none, mild, moderate to severe. Participants excluded from the study included those who had other infectious and noninfectious diseases, such as hepatitis A, C, D, and E viruses; human immunodeficiency virus (HIV); cytomegalovirus; and Epstein-Barr virus; pregnant or breastfeeding women; patients younger than 18 years or older than 55 years; patients who had undergone liver transplantation; patients with alcoholism, autoimmune liver diseases, cirrhosis, and evidence of hepatocellular carcinoma (HCC); and patients taking antiviral and immunosuppressive drugs.
CHB infection was diagnosed in patients by a physician who is an expert in infectious diseases (M.K.), via previous clinical and experimental reports and according to the Guide to Prevention and Treatment in Viral Hepatitis. 12 We evaluated degrees of depression and anxiety using standard questionnaires. 13 The study protocol was approved by the Ethical Board of Rafsanjan University of Medical Sciences (code: IR.RUMS.REC.1394.128). All participants filled out a written informed-consent form before completion of the depression and anxiety questionnaires and before blood-specimen collection.
Evaluation of Depression and Anxiety
An expert psychologist (R.B.) assessed depression and anxiety according to the Beck Depression Inventory II (BDI II) and the Hamilton Anxiety Rating Scale (HAM-A), respectively.
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HBV-DNA Extraction and Quantification
HBV-DNA was purified and quantified using commercial kits from Cinnaclon Company and Primer Design Company, respectively.
HBsAg, HBsAb, HBeAg, IL-6, IL-8, TNF-α, and TGF-β Detection
We evaluated IL-6, IL-8, TNF-α, and TGF-β using commercial enzyme-linked immunsorbant assay (ELISA) kits from eBiosciences Company according to manufacturer guidelines.
Data Analysis and Statistical Methods
Numerical variables are presented as mean (SD) or median (interquartile range), whereas categorized variables are summarized by absolute frequencies and percentages. Continuous variables were compared using the Student's t-test across patients with CHB infection and healthy controls. We also compared continuous variables using Kruskal-Wallis H testing across severity of depression/anxiety defined by normal, mild, moderate, and severe.
We used SPSS software, version 15.0 (SPSS Inc.) for statistical analysis. P values were 2-tailed, with statistical significance less than .05.
Results
The results showed that, of the 60 patients with CHB infection, 40 (66.6%), 10 (16.7%), 6 (10.0%), and 4 (6.7%) had no, mild, moderate, and severe depression, respectively; also, 14 (23.3%), 18 (30.0%), 22 (36.7%), and 6 (10.0%) patients had no, mild, moderate, and severe anxiety, respectively. Based on the low number of patients in the moderate and severe depression and anxiety categories, we analyzed cytokine serum levels in patients with no, mild and moderate to severe depression and anxiety.
All of the patients had detectable HBV DNA. The mean (SD) serum levels of IL-6, IL-8, TNF-α, and TGF-β in patients with CHB infection were 9. Figure 1) . The results of our statistical analysis demonstrated that the differences were significant in IL-6 (P = .02), IL-8 (P <.001), and TGF-β (P <.001) but not in TNF-α (P = .46) between the 2 groups.
The results demonstrated that serum levels of IL-6, IL-8, TNF-α, and TGF-β were not radically changed in patients with CHB infection who had various degrees of depression ( Figure 2 and Table 1 ) and anxiety ( Figure 3 and Table 2) , with the exception of TGF-β, which decreased in patients with CHB infection who had mild depression compared with patients with CHB infection who had no and mild to severe depression ( Figure 2 and Table 1) .
Discussion
It has been demonstrated that patients with CHB infection have chronic inflammation that is associated with certain liver complications, such as cirrhosis and HCC. 7 The immune system consists of several molecules and cells that can participate in induction of inflammation; however, the roles of each molecule in induction of chronic inflammation in CHB infection are yet to be clarified, to our knowledge.
The results of the current study reveal that serum levels of IL-8 were increased but IL-6 and TGF-β levels were decreased in patients with CHB infection, compared with healthy controls.
According to the results and based on the fact that IL-8 is an immune cell attractor, we hypothesize that IL-8 may induce inflammation in the liver by infiltration of immune cells, including macrophages and neutrophils. A previous investigation 14 reported that IL-6, in association with TGF-β, induces development of Th17, an important immune cell, to induce inflammation, but TGF-β has anti-inflammatory effects by itself. The results revealed that serum levels of both cytokines (IL-6 and TGF-β) had decreased in patients with CHB infection. Accordingly, chronic inflammation in patients with CHB infection seems to be related to downregulation of TGF-β but not via Th17 development. We noted that our previous investigations showed that serum levels of TGF-β increased in patients with CHB infection. 10 Thus, current patients with CHB infection seem to have characteristics that result in downregulation of TGF-β.
It has been proposed that patients with CHB infection tend to have psychiatric disorders, such as depression and anxiety. 15 The results of the current study show that 33.4% and 76.7% of patients with CHB infection also have depression and anxiety, respectively. Similarly, the results of a previous study demonstrate that 36.6% of patients with CHB infection also have depression and 40% have anxiety. 2 Thus, depression and anxiety appear to be prevalent among patients with CHB infection and may be considered immunomodulator factors. Based on the results, which confirm the high prevalence of depression in patients with CHB infection and the role of depression on declination of TGF-β, we conclude that depression might lead to downregulation of TGF-β and, subsequently, induction of inflammation in these patients. A previous study by 2 of us on the intracellular signaling molecules involved in the toll-like receptor (TLR) signaling pathways showed that the expression of the molecules did not differ among patients with CHB infection experiencing various degrees of depression and anxiety.
2 TLRs and their signaling molecules induce expression of proinflammatory cytokines. Therefore, based on the results, depression appears to downregulate TGF-β in patients with CHB infection independent of the actions of TLRs.
To our knowledge, this study is the first project to evaluate the effects of depression and anxiety on the expression of IL-6, IL-8, TNF-α, and TGF-β in patients with CHB infection.
Also, previous studies in patients not infected with CHB revealed that the expression of 2 adaptor proteins in the TLR signaling pathways, namely, toll interleukin 1 receptor (TIR)-domain-containing adapter-inducing interferon-β (TRIF) and myeloid differentiation primary response (MYD88), were unchanged, 16 but nuclear factor kappa-lightchain-enhancer of activated B cells (NF-κB) was significantly decreased 17 in patients with depression compared with healthy controls without depression. Thus, increased expression of IL-8 in the patients with CHB infection and depression may not be dependent on NF-κB, and other transcription factors may participate in cytokine expression. Collectively, due to the important roles played by psychiatric disorders on immune-system-related molecules, additional investigations on other immune-system-related molecules, including other cytokines, can improve our knowledge regarding the effect of psychiatric disorders on immune responses in HBV infection.
Our results revealed wide distributions in cytokines levels among the studied groups. Based on the fact that these cytokines are not ready to release macromolecules and must produced when needed, production of these cells can be increased widely. However, given that other interfered factors, such as occupational stress, can influence expression of cytokines, the range of cytokine production is wide in the human population. This finding is the limit of this and several other studies in this field in which interfering factors have not been evaluated in patient cohorts. Still, we hope that further studies will continue to elucidate the role of cytokines in CHB infection, depression, and anxiety. LM
